Multiple endocrine neoplasia type 2 laboratory findings: Difference between revisions
No edit summary |
|||
Line 17: | Line 17: | ||
| style="background: #B8B8B8; padding: 5px;"| Elevated norepinephrine<br>Elevated metanephrine<br>Elevated vanillylmandelic acid | | style="background: #B8B8B8; padding: 5px;"| Elevated norepinephrine<br>Elevated metanephrine<br>Elevated vanillylmandelic acid | ||
|} | |} | ||
{| | |||
|- | |||
| valign=top | | |||
{|style="border: 0px; font-size: 90%; margin: 3px; width: 700px;" align=center | |||
! style="padding: 0 5px; background: #4479BA" align=center |{{fontcolor|#FFF| Laboratory tests}} | |||
! style="background:#4479BA;" align=center|{{fontcolor|#FFF| Normal Range}} | |||
! style="background:#4479BA; width: 300px" align=center|{{fontcolor|#FFF| Abnormal value}} | |||
|- | |||
| style="padding: 0 5px; background: #4479BA" colspan=3 |{{fontcolor|#FFF| Metabolic}} | |||
|- | |||
! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|Serum phosphate | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left| 2.4 to 4.1 mg/dL | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left| <2.4 or >4.1 | |||
|- | |||
! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|Serum calcium | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|8.5-10.2 mg/dL | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|<8.5 or >10.2 mg/dL | |||
|- | |||
! style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|Serum calcitonin | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|less than 10pg/mL | |||
| style="padding: 0 5px; font-size: 100%; background: #f0f0f0" align=left|<8.5 or >10.2 mg/dL | |||
|}} | |||
==Reference== | ==Reference== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:31, 25 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
Multiple endocrine neoplasia type 2 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory Tests
- Some of the laboratory findings of multiple endocrine neoplasia type 2 is tabulated below.
Test | Findings |
---|---|
Metabolic | Hypophosphatemia Hypercalcemia Elevated calcitonin Elevated epinephrine Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid Elevated parathyroid hormone Decreased serum phosphate Elevated pentagastrin |
Urinalysis | Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid |
Reference |